These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 316435)

  • 1. Acquired von Willebrand's syndrome with IgM inhibitor against von Willebrand's factor.
    Gouault-Heilmann M; Dumont MD; Intrator L; Chenal C; Lejonc JL
    J Clin Pathol; 1979 Oct; 32(10):1030-5. PubMed ID: 316435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of inhibitory and binding characteristics of an antibody causing acquired von Willebrand syndrome: an assay for von Willebrand factor binding by antibody.
    Fricke WA; Brinkhous KM; Garris JB; Roberts HR
    Blood; 1985 Sep; 66(3):562-9. PubMed ID: 3927998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Precipitating antibodies to factor VIII/von Willebrand factor in von Willebrand's disease: effects on replacement therapy.
    Mannucci PM; Ruggeri ZM; Ciavarella N; Kazatchkine MD; Mowbray JF
    Blood; 1981 Jan; 57(1):25-31. PubMed ID: 6778538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies to factor VIII-von Willebrand factor in congenital and acquired von Willebrand's disease.
    Mannucci PM; Mari D
    Prog Clin Biol Res; 1984; 150():109-22. PubMed ID: 6431422
    [No Abstract]   [Full Text] [Related]  

  • 5. Factor VIII/von Willebrand factor binding to von Willebrand's disease platelets.
    Gralnick HR; Williams SB; Shafer BC; Corash L
    Blood; 1982 Aug; 60(2):328-32. PubMed ID: 6807372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acquired von Willebrand's syndrome due to an inhibitor of IgG specific for von Willebrand's factor in polycythemia rubra vera.
    Mohri H; Ohkubo T
    Acta Haematol; 1987; 78(4):258-64. PubMed ID: 3122493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electrophoretic heterogeneity of normal factor VIII/Von Willebrand protein, and abnormal electrophoretic mobility in patients with Von Willebrand's disease.
    Sultan Y; Simeon J; Caen JP
    J Lab Clin Med; 1976 Feb; 87(2):185-94. PubMed ID: 1082003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stabilization of factor VIII in plasma by the von Willebrand factor. Studies on posttransfusion and dissociated factor VIII and in patients with von Willebrand's disease.
    Weiss HJ; Sussman II; Hoyer LW
    J Clin Invest; 1977 Aug; 60(2):390-404. PubMed ID: 17621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. von Willebrand's disease antigen II. A new plasma and platelet antigen deficient in severe von Willebrand's disease.
    Montgomery RR; Zimmerman TS
    J Clin Invest; 1978 Jun; 61(6):1498-507. PubMed ID: 307007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carbohydrate deficiency of the factor VIII/von Willebrand factor Protein in von Willebrand's disease variants.
    Gralnick HR; Coller BS; Sultan Y
    Science; 1976 Apr; 192(4234):56-9. PubMed ID: 1083071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship of the properties of antihemophilic factor (factor VIII) that support ristocetin-induced platelet agglutination (factor VIIIR:RC) and platelet retention by glass beads as demonstrated by a monoclonal antibody.
    Ogata K; Saito H; Ratnoff OD
    Blood; 1983 Jan; 61(1):27-35. PubMed ID: 6401215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acquired von Willebrand's syndrome with lupus-like serology.
    Igarashi N; Miura M; Kato E; Matsuda T; Itoh K; Abildgaard CF; Shimizu M; Koizumi S; Sato T; Taniguchi N
    Am J Pediatr Hematol Oncol; 1989; 11(1):32-5. PubMed ID: 2496614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative assay of a plasma factor deficient in von Willebrand's disease that is necessary for platelet aggregation. Relationship to factor VIII procoagulant activity and antigen content.
    Weiss HJ; Hoyer LW; Rickles FR; Varma A; Rogers J
    J Clin Invest; 1973 Nov; 52(11):2708-16. PubMed ID: 4542944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defective ristocetin-induced platelet aggregation in von Willebrand's disease and its correction by factor VIII.
    Weiss HJ; Rogers J; Brand H
    J Clin Invest; 1973 Nov; 52(11):2697-707. PubMed ID: 4201262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Ultrasonic-exposed factor VIII and von Willebrand's disease].
    Casillas G; Simonetti C; Kempfer C
    Medicina (B Aires); 1981; 41 Suppl():253-6. PubMed ID: 6808289
    [No Abstract]   [Full Text] [Related]  

  • 16. Von Willebrand's disease: combined qualitative and quantitative abnormalities.
    Gralnick HR; Sultan Y; Coller BS
    N Engl J Med; 1977 May; 296(18):1024-30. PubMed ID: 300468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acquired von Willebrand's disease: demonstration of a circulating inhibitor to the factor VIII complex in four cases.
    Sampson BM; Greaves M; Malia RG; Preston FE
    Br J Haematol; 1983 Jun; 54(2):233-44. PubMed ID: 6405778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of epinephrine infusion in patients with von Willebrand's disease.
    Rickles FR; Hoyer LW; Rick ME; Ahr DJ
    J Clin Invest; 1976 Jun; 57(6):1618-25. PubMed ID: 1084352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogens and surgery in women with von Willebrand's disease.
    Alperin JB
    Am J Med; 1982 Sep; 73(3):367-71. PubMed ID: 6981997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acquired von Willebrand's syndrome during autoimmune disorder.
    Pizzuto J; Ambriz R; de la Paz Reyna M; Monrroy LM; Morales MR; Aviles A; Conte G; Enriquez R
    Thromb Haemost; 1980 Feb; 42(5):1523-8. PubMed ID: 6966081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.